Evidence map›Paper›PMID 40624606›Full record

ArticleBMC nephrology2025

Unveiling hidden contaminants: a systematic quantification and characterization of microplastics in hemodialysis and peritoneal dialysis fluids.

Ekrem Kara, Kamil Konur, Yasemen Şentürk Koca, Ülgen Aytan

Abstract read
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Effects of micro and nano plastics on renal health.World journal of nephrology · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ekrem KaraFaculty of Medicine, Department of Nephrology, Recep Tayyip Erdogan University, Rize, Türkiye. ekrem.kara@erdogan.edu.tr.
Kamil KonurFaculty of Medicine, Department of Internal Medicine, Recep Tayyip Erdogan University, Rize, Türkiye.
Yasemen Şentürk KocaMicroplastic Research Unit, Faculty of Fisheries, Recep Tayyip Erdogan University, Rize, Türkiye.
Ülgen AytanMicroplastic Research Unit, Faculty of Fisheries, Recep Tayyip Erdogan University, Rize, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microplastics (MPs) are an emerging environmental and biomedical concern due to their potential bioaccumulation and toxic effects. Given the extensive exposure of dialysis patients to large volumes of dialysate and water, the presence of MPs in dialysis solutions raises concerns regarding chronic exposure and systemic implications. This study systematically quantifies and characterizes MPs in hemodialysis (HD) and peritoneal dialysis (PD) fluids, investigating their sources and potential health risks. A total of 30 dialysis solution samples were analysed (revealing 36 suspect particles) using advanced spectroscopic techniques, including Fourier-transform infrared (FT-IR) spectroscopy, to identify polymer compositions. MPs predominantly fibers, were detected in all tested solutions, with polyethylene (PE), polyvinyl chloride (PVC), and ethylene-vinyl acetate (EVA) as the primary polymers. Statistical analyses confirmed significant variability in MP contamination across different dialysis fluids. Hemodialysis and peritoneal dialysis solutions show no statistically significant difference in MP concentration (HD: 0.29 ± 0.16 mp.L⁻¹, PD: 0.34 ± 0.02 mp.L⁻¹, p = 0.86). MP particles in HD solutions (1.31 ± 0.98 mm) are significantly larger than those in PD solutions (0.64 ± 0.43 mm) (p = 0.030). Despite similar MP concentrations, PD patients are estimated to be exposed to ~ 50% more MPs weekly than HD patients (9.57 ± 5.28 vs. 14.28 ± 0.84 mp. L⁻¹, p < 0.001). These findings highlight a potential, yet underrecognized, source of MP exposure in dialysis patients, necessitating further investigation into the implications of chronic MP absorption on renal function and systemic health. Regulatory policies should prioritize improved filtration techniques, alternative polymer-free materials, and stricter quality control measures to mitigate MP contamination in medical solutions. Future research should explore the long-term effects of MP exposure in dialysis-dependent individuals and refine analytical methodologies for contamination assessment.

Indexed as

Dialysis SolutionsHemodialysis SolutionsMicroplasticsPeritoneal DialysisRenal DialysisHumansDialysis SolutionsHemodialysis SolutionsMicroplasticsDialysisExposureHuman healthMicroplastics

Identifiers

PMID40624606
PMCPMC12235760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.